We are live on ! Find out more
AC

Aristides Capital Portfolio holdings

AUM $462M
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+28.94%
3 Year Est. Return
+109.78%
5 Year Est. Return
+150.66%
10 Year Est. Return
AUM
$144M
AUM Growth
+$11.5M
Cap. Flow
+$34.7M
Cap. Flow %
24.07%
Top 10 Hldgs %
59.33%
Holding
134
New
35
Increased
18
Reduced
21
Closed
41

Sector Composition

Rank Sector Weight
1 Financials 10%
2 Consumer Discretionary 6.82%
3 Communication Services 6.09%
4 Technology 5.81%
5 Industrials 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
126
DELISTED
Myovant Sciences Ltd.
MYOV
-67,000
Closed -$1.38M
RTLR
127
DELISTED
Rattler Midstream LP Common Units
RTLR
-64,861
Closed -$629K
EPZM
128
DELISTED
Epizyme, Inc
EPZM
-16,552
Closed -$266K
SOLY
129
DELISTED
Soliton, Inc.
SOLY
-51,363
Closed -$400K
THCBU
130
DELISTED
Tuscan Holdings Corp. Unit
THCBU
-40,000
Closed -$428K
ROCHU
131
DELISTED
Roth CH Acquisition I Co. Unit
ROCHU
-80,000
Closed -$804K
CNXM
132
DELISTED
CNX Midstream Partners LP
CNXM
-35,756
Closed -$238K

Similar funds

Aristides Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Aristides Capital held 134 positions worth $144M, up 8.7% from $133M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Aristides Capital deployed $34.7M of net new capital in Q3 2020, opening 35 new positions and adding to 18 existing holdings. Its largest new stake was ClearBridge MLP and Midstream Fund Inc.: 278,254 shares worth $3.08M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $4.93M trimmed.

  • Aristides Capital's largest Q3 2020 buy was ClearBridge MLP and Midstream Fund Inc.: 278,254 shares worth $3.08M.
  • Aristides Capital added most to Tortoise Energy Infrastructure Corp in Q3 2020, an estimated $1.04M increase.
  • Aristides Capital's biggest Q3 2020 reduction was iShares Biotechnology ETF, cutting an estimated $4.93M.
  • Aristides Capital fully exited Workhorse Group in Q3 2020, selling an estimated $1.46M.
  • Aristides Capital's ten largest holdings make up 59% of its $144M portfolio in Q3 2020.
  • Aristides Capital opened 35 new positions and closed 41 in Q3 2020.
  • Aristides Capital's portfolio value rose 8.7% quarter-over-quarter to $144M.

Based on Aristides Capital's 13F filing for Q3 2020, filed 12 Nov 2020.